Cliquez ici pour lire l'article
READ THIS ARTICLE...
Article tiré du magazine "Point de vue"
Click here to read the article
Article from the magazine "Point de vue"
The orthokeratology (Ortho-K) effect was first observed as a side effect of contact lenses made of Poly methyl methacrylate (PMMA), which flattened in their radius of curvature over time. “What started as a method to reduce temporarily the refractive error of nearsighted individuals evolved, with the help of innovative design choices, to advanced engineering of the corneal surface of the eye,” explains Dr. Cary M. Herzberg, OD FIAO, president of the International Academy of Orthokeratology and Myopia Control (IAOMC).
With the optics and resulting aberrations of an oblate corneal surface including spherical aberration, advanced design choices could provide solutions for progressive myopia and presbyopia. Ortho-K also attracted maverick practitioners, who brought a spirit of imaginative innovation to the world. “It has been my honor to have led several of these organizations and to have helped found the international academy, which now spans the globe,” continued Dr. Herzberg. “Our mission is in part to help find solutions to the myopia epidemic which threatens the eye health of present and future generations”.
As our world grows and develops, our vision is getting worse. That’s the takeaway from an important body of research data about the world’s vision, with a laser focus on myopia and its impact.
The statistics are alarming – myopia is projected to affect almost half of the world’s population by 2050. The consequences are just as unsettling, as myopia, when left uncorrected, can lead to severe vision impairment and even blindness. By mid-century, nearly five billion will have the vision impairment with about one billion suffering from high myopia. In the United States and Canada, the number of myopic is estimated to climb to 260 million, or close to half of the population, up from 89 million in 2000; and high myopia cases jump an astounding five times to 66 million by that year.
These are part of the findings of a meta-analysis by the Brien Holden Vision Institute of 145 studies covering 2.1 million people. Also known as nearsightedness, myopia is a refractive error that causes items close by to be seen distinctly while distance vision is blurry. High myopia is a severe form in which the eyeball becomes too long and can lead to retinopathies or even retinal detachment.
Cliquez ici pour lire l'articleSurprisingly enough for a non-infectious condition, myopia is reaching pandemic proportions across the world.
In the US and Europe, the prevalence of myopia has doubled over the last century, reaching 40-50% of young people (aged < 35) today. East Asia has been hit particularly badly. In countries such as Singapore, China and Korea, myopia affects around 80-90% of urban teenagers, compared to 10-20% sixty years ago. Recent work from the Brien Holden Vision Institute (BHVI) estimates that by 2050, five billion people, or half the world’s population, will be myopic and one billion, or 10%, highly myopic. A record-high myopia of -108 diopters has recently been compensated in Slovakia, Europe, representing new challenges for eye care practitioners and the ophthalmic industry. While the direct global socio-economic impact of myopia has not yet been determined, the economic burden of uncorrected refractive error (URE), which is largely caused by myopia, is estimated to be more than US$269 billion (per annum) – and this number is growing as the pandemic spreads.
Over the past few months there has been a notable increase in alarming publications in scientific journals and the media on the myopia crisis. However, leading research centers and medical universities have been vigorously focused for some time on furthering understanding of the condition and developing new treatments for it. Etiology investigations have uncovered that myopia onset and its progression in children are correlations of both hereditary (nature) and environmental factors (nurture). The latter can be modified by encouraging greater exposure to natural light through outdoor activities and adopting good reading posture. We take the opportunity in this issue to share some perspectives from 25 experts – scientists and eye care practitioners – taking a look at their approach to understanding, correcting and treating myopia, plus preventing its progression in children.
Biochemical research for the myopia pathogenic mechanism will continue to be a hot topic. Luckily, the progress made over the past decade gives us reason for hope. At present, the overwhelming majority of myopia cases can be corrected with regular prescription eyeglasses, contact lenses or refractive surgery. There are also the solutions that correct and control myopia progression in children. Specific multifocal contact lenses, Myopilux® ophthalmic lenses and orthokeratology (Ortho-K) are all recognized as safe and effective procedures in the long term. While pharmacological interventions such as atropine eye drops at low concentration do not correct myopia, they effectively control its progression. There is no doubt tailor-made solutions help patients live their life to the fullest.
Myopia rise and vision health issues left in its wake.